Combining alum with a TLR7-nanoparticle adjuvant enhances vaccine-elicited humoral and cellular immunity

The vaccine adjuvant formulation combining Alum and TLR7-NP broadens antigen-presenting cell engagement, enhances cross-reactive antibody responses, and strengthens CD4 ⁺ and CD8 ⁺ T cell immunity.